We think you have liked this presentation. If you wish to download it, please recommend it to your friends in any social system. Share buttons are a little bit lower. Thank you!
Presentation is loading. Please wait.
Published byPamela Hutchinson
Modified over 5 years ago
Survival after resection of synchronous non–small cell lung cancer Thomas Fabian, MD, FCCP, Ayesha S. Bryant, MSPH, MD, Angela L. Mouhlas, MD, John A. Federico, MD, Robert J. Cerfolio, MD, FACS, FCCP The Journal of Thoracic and Cardiovascular Surgery Volume 142, Issue 3, Pages (September 2011) DOI: /j.jtcvs Copyright © Terms and Conditions
Figure 1 Location of non–small cell lung cancer: A, all tumors; B, bilateral tumors. The Journal of Thoracic and Cardiovascular Surgery , DOI: ( /j.jtcvs ) Copyright © Terms and Conditions
Figure 2 Kaplan-Meier survival curve depicting actual overall survival (N = 67) and 5-year survival (52%). Lighter lines indicate 95% confidence intervals. The Journal of Thoracic and Cardiovascular Surgery , DOI: ( /j.jtcvs ) Copyright © Terms and Conditions
Figure 3 The Kaplan-Meier overall 5-year survival by side of resection and histologic type. The Journal of Thoracic and Cardiovascular Surgery , DOI: ( /j.jtcvs ) Copyright © Terms and Conditions
Photodynamic Laser Therapy for Lesions in the Airway
Size matters: A comparison of T1 and T2 peripheral non–small-cell lung cancers treated with stereotactic body radiation therapy (SBRT) Neal E. Dunlap,
Effect of Barrett's esophagus surveillance on esophageal preservation, tumor stage, and survival with esophageal adenocarcinoma Kimberly S. Grant, MD,
The eighth edition TNM stage classification for lung cancer: What does it mean on main street? Frank C. Detterbeck, MD The Journal of Thoracic and Cardiovascular.
Complete Thoracic Mediastinal Lymphadenectomy Leads to a Higher Rate of Pathologically Proven N2 Disease in Patients With Non-Small Cell Lung Cancer
Impact of Race on Outcomes of Patients with Non-small Cell Lung Cancer
Characteristics and outcomes of secondary nodules identified on initial computed tomography scan for patients undergoing resection for primary non–small.
Local recurrence after surgery for non–small cell lung cancer: A recursive partitioning analysis of multi-institutional data Chris R. Kelsey, MD, Kristin.
One in every 14 patients with early-stage lung cancer is not being treated! Benny Weksler, MD, MBA The Journal of Thoracic and Cardiovascular Surgery
It is not just about surgery versus stereotactic ablative radiotherapy, it is about curing as many patients with lung cancer as possible Alessandro Brunelli,
Sotiris C. Stamou, MD, PhD, Michael Robich, MD, MSPH, Robert E
Effect of tumor size on prognosis in patients with non–small cell lung cancer: The role of segmentectomy as a type of lesser resection Morihito Okada,
Lung cancer screening: No more excuses
Paul J. Scheel, BS, Traves D. Crabtree, MD, Jennifer M
Impact of tumor size on outcomes after anatomic lung resection for stage 1A non–small cell lung cancer based on the current staging system Shamus R.
A risk factor paper on air leaks: Now it's time for treatment strategy papers from the only 5-tool hospital athlete—the thoracic surgeon Robert James.
The effect of center volume on the incidence of postoperative complications and their impact on survival after lung transplantation Arman Kilic, MD,
Interventional radiology suite or hybrid operating room: Which is the best for lung nodule localization? Robert B. Cameron, MD The Journal of Thoracic.
The prognostic impact of microRNA sequence polymorphisms on the recurrence of patients with completely resected non–small cell lung cancer Kyong-Ah Yoon,
Outcomes of unexpected pathologic N1 and N2 disease after video-assisted thoracic surgery lobectomy for clinical stage I non–small cell lung cancer Hong.
© 2024 SlidePlayer.com Inc. All rights reserved.